ACHIEVEMENT OF LOW DISEASE ACTIVITY IN PATIENTS INITIATING INFLIXIMAB WITH AND WITHOUT DOSE ESCALATION

被引：0
|
作者：
Cohen, S. [1 ]
Reed, G. [2 ]
Magner, R. [3 ]
Kafka, S. [4 ]
Ellis, L. [4 ]
DeHoratius, R. J. [5 ]
Greenberg, J. D. [6 ]
机构：
[1] Metroplex Clin Res Ctr, Dallas, TX USA
[2] LLC Mass Med Sch, Corrona, Southborough, MA USA
[3] U Mass Med Sch, Worcester, MA USA
[4] Janssen Sci Affairs LLC, Horsham, PA USA
[5] Horsham Phila, LLC Kimmel Sch Med, Janssen Sci Affairs, Horsham, PA USA
[6] NYU, LLC, Sch Med, Corrona, Southborough, NY USA
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2016年 / 75卷
关键词：
D O I：
10.1136/annrheumdis-2016-eular.2771
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
THU0156
引用
收藏
页码：238 / 239
页数：2
相关论文
共 50 条
  • [1] Successful Dose De-Escalation of Infliximab in Rheumatoid Arthritis Patients with Stable Low Disease Activity and Treatment
    van der Maas, Aatke
    den Broeder, Alfons
    van den Hoogen, Frank H. J.
    Van Riel, Piet
    van den Bemt, Bart J. F.
    ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S666 - S666
  • [2] COMPARISON OF DOSE ESCALATION AND COSTS OF DOSE ESCALATION BETWEEN PATIENTS WITH RHEUMATOID ARTHRITIS INITIATING BIOLOGIC TREATMENT WITH ETANERCEPT, ADALIMUMAB, OR INFLIXIMAB
    Garces, K.
    Thorne, C.
    Boire, G.
    Chow, A.
    Poulin-Costello, M.
    Walker, V
    Haraoui, B.
    VALUE IN HEALTH, 2016, 19 (03) : A229 - A230
  • [3] THE EFFECT OF INFLIXIMAB DOSE ESCALATION IN INFLAMMATORY BOWEL DISEASE PATIENTS WITH ANTIBODIES TO INFLIXIMAB
    Tun, Gloria S. Z.
    Marshall, Laura
    Thompson, Laura
    Campbell, Rebecca
    Hale, Melissa F.
    Chew, Thean S.
    Brooks, Alenka J.
    Robinson, Kerry
    Lobo, Alan J.
    GUT, 2019, 68 : A61 - A62
  • [4] The effect of infliximab dose escalation in inflammatory bowel disease patients with antibodies to infliximab
    Tun, Gloria S. Z.
    Robinson, Kerry
    Marshall, Laura
    Wright, Alison
    Thompson, Laura
    Wild, Graeme
    Sargur, Ravishankar
    Brooks, Alenka J.
    Hale, Melissa F.
    Chew, Thean S.
    Lobo, Alan J.
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2022, 34 (03) : 295 - 301
  • [5] Outcomes after dose escalation of infliximab in Japanese patients with Crohn's disease
    Sako, M.
    Kawaguchi, T.
    Hirayama, A.
    Fukushi, G.
    Hayama, K.
    Fujiwara, T.
    Yoshimura, N.
    Takazoe, M.
    JOURNAL OF CROHNS & COLITIS, 2014, 8 : S231 - S231
  • [6] Outcomes of infliximab dose escalation in patients with rheumatoid arthritis
    Cohen, Stanley B.
    Kremer, Joel M.
    Dandreo, Kimberly J.
    Reed, George W.
    Magner, Robert
    Shan, Ying
    Kafka, Shelly
    DeHoratius, Raphael J.
    Ellis, Lorie
    Parenti, Dennis
    CLINICAL RHEUMATOLOGY, 2019, 38 (09) : 2501 - 2508
  • [7] Outcomes of infliximab dose escalation in patients with rheumatoid arthritis
    Stanley B. Cohen
    Joel M. Kremer
    Kimberly J. Dandreo
    George W. Reed
    Robert Magner
    Ying Shan
    Shelly Kafka
    Raphael J. DeHoratius
    Lorie Ellis
    Dennis Parenti
    Clinical Rheumatology, 2019, 38 : 2501 - 2508
  • [8] TRENDS IN THE ACHIEVEMENT OF LOW DISEASE ACTIVITY AMONG A US NATIONAL SAMPLE OF RHEUMATOID ARTHRITIS PATIENTS INITIATING BIOLOGICS
    Harrold, L. R.
    Palmer, J. L.
    Curtis, J. R.
    Greenberg, J. D.
    Pappas, D. A.
    Kremer, J. M.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 199 - 199
  • [9] Reactive dose escalation of infliximab in patients with Crohn's disease in TAILORIX leads to improved outcomes
    Dreesen, E.
    Laharie, D.
    Lambrecht, G.
    Bossuyt, P.
    Buisson, A.
    Filippi, J.
    Van Hootegem, P.
    D'Haens, G.
    Vermeire, S.
    Gils, A.
    JOURNAL OF CROHNS & COLITIS, 2018, 12 : S396 - S397
  • [10] REACTIVE DOSE ESCALATION OF INFLIXIMAB IN PATIENTS WITH CROHN'S DISEASE IN TAILORIX LEADS TO IMPROVED OUTCOMES
    Dreesen, Erwin
    Laharie, David
    Lambrecht, Guy
    Bossuyt, Peter
    Buisson, Anthony
    Filippi, Jerome
    Van Hootegem, Philippe
    D'Haens, Geert R.
    Vermeire, Severine
    Gils, Ann
    GASTROENTEROLOGY, 2018, 154 (06) : S823 - S824
12345